Thursday 3 October / 17.15-18.45
How to prevent thrombo-embolic events in AF patients – interventional vs medical strategies
W. Jung / Villingen-Schwenningen, Germany
S. Saksena / New Brunswick, USA
- Detection of silent AF and therapeutic consequences. Which is the appropriate tool and when should OAC be started?
Brachmann / Coburg, Germany
- Is the LAA-occluder a safe and reliable alternative to OAC in patients at high bleeding risk? Which technique to prefer and how much and how long is platelet inhibition needed?
Lewalter / Munich, Germany
- Catheter ablation of AF – for which patients OAC may be stopped after the procedure?
E.G. Vester / Düsseldorf, Germany
- Secondary stroke prevention in patients with cryptogenic stroke – Lessons from randomized trials
Freedman / Sydney, Australia